News for Anixa Biosciences, Inc. (ANIX)

PR NewswireSAN JOSE, Calif., May 19, 2025 SAN JOSE, Calif., May 19, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX),

PR NewswireSAN JOSE, May 12, 2025 SAN JOSE, May 12, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology

PR NewswireSAN JOSE, Calif., April 30, 2025 SAN JOSE, Calif., April 30, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: AN

Anixa Biosciences (ANIX) to present at H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20, 2025. The event will be held at Nasdaq World

PR NewswireSAN JOSE, Calif., April 14, 2025 SAN JOSE, Calif., April 14, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: AN

Anixa Biosciences (ANIX) receives a Notice of Allowance from the USPTO for its CAR-T technology patent. The patent is exclusively licensed to Anixa from

Anixa Biosciences (ANIX) has announced a significant milestone in its development of cancer treatment technologies, receiving a Notice of Allowance from the Uni

PR NewswireSAN JOSE, Calif., April 9, 2025 Patent Broadens Immunogenic Compositions for Preventive Vaccine ApproachSAN JOSE, Calif., April 9, 2025 /PRNewsw

Anixa Biosciences (ANIX) receives a Notice of Allowance from the USPTO for a new breast cancer vaccine patent. The patent covers immunization methods us

PR NewswireSAN JOSE, Calif., March 25, 2025 VERDI's personalized vaccines have demonstrated safety and efficacy in cancer patientsSAN JOSE, Calif., March 2

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

PR NewswireSAN JOSE, Calif., March 17, 2025 SAN JOSE, Calif., March 17, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: AN

PR NewswireSAN JOSE, Calif., March 10, 2025 SAN JOSE, Calif., March 10, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: AN

PR NewswireSAN JOSE, Calif., Feb. 26, 2025 SAN JOSE, Calif., Feb. 26, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX

PR NewswireSAN JOSE, Calif., Feb. 25, 2025 SAN JOSE, Calif., Feb. 25, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX

PR NewswireSAN JOSE, Calif., Feb. 24, 2025 SAN JOSE, Calif., Feb. 24, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX

PR NewswireSAN JOSE, Calif., Feb. 18, 2025 Amendment expands the potential benefits of CAR-T therapy allowing a second dose and includes more ovarian cance

PR NewswireSAN JOSE, Calif., Jan. 21, 2025 SAN JOSE, Calif., Jan. 21, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX

On January 17, 2025, Titterton Lewis H Jr, a Director at Anixa Biosciences Inc, purchased 10,000 shares of the company. Following this transaction, the insider